Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome manifesting as hamartomas in various organs. [1, 2] Vision loss in patients with TSC may occur due to astrocytic hamartoma affecting macula or Optic nerve. [3] Rarely papilledema due to supbependymal nodule may result in bilateral pale disc and subsequent vision loss. We report a patient with vision loss due to papilledema secondary to subependymal nodule. 
Case Report

Comment
Von Recklinghausen first described tuberous sclerosis complex (TSC). [1] About two-third of the cases are sporadic in nature while one-third cases have autosomal dominant inheritance pattern. [2] TSC is characterized by facial angiofibromas, ash-leaf spots, cardiac rhabdomyoma, renal angiomyolipoma, and retinal astrocytic hamartomas. [2] Our patient presented with the classical Vogt triad of mental retardation, epilepsy, and adenoma sebaceum. [3] Genetic testing was not done and hence inheritance pattern could not be clearly ascertained. However, family history of similar condition was not noted.
Retinal astrocytic hamartomas occur in about 50% of patients, and in 50% of patients, it is bilateral. [2] Our patient presented with bilateral multiple, small, sessile noncalcified mass lesions at the posterior pole. However, the cause of poor vision in our patient was assigned to optic neuropathy secondary to chronic papilledema. A report by Chong et al. has demonstrated that timely excision of the mass lesion from the foramen of Munro resulted in resolution of papilloedema and restoration of vision. [4] Due to delayed presentation and lack of ophthalmic referral, visual outcome in our patient was poor.
Conclusion
Vision loss in tuberous sclerosis can occur due to secondary optic neuropathy. Regular ophthalmic examination is necessary to avoid irreversible visual loss. Indian Journal of Ophthalmology reported in the journal. The patient's parents understand that name and initial will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
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